155 related articles for article (PubMed ID: 9703366)
1. Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells.
Nagasawa K; Ohnishi N; Yokoyama T
Jpn J Cancer Res; 1998 Jun; 89(6):673-80. PubMed ID: 9703366
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the nucleoside transport system to doxorubicin transport in HL60 cells but not in mononuclear cells.
Nagasawa K; Fumihara T; Ohnishi N; Yokoyama T
Jpn J Cancer Res; 1999 Jul; 90(7):781-7. PubMed ID: 10470292
[TBL] [Abstract][Full Text] [Related]
3. Transport mechanisms of idarubicin, an anthracycline derivative, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs.
Nagasawa K; Ohnishi N; Yokoyama T
Jpn J Cancer Res; 1997 Aug; 88(8):750-9. PubMed ID: 9330607
[TBL] [Abstract][Full Text] [Related]
4. Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells.
Nagai K; Nagasawa K; Ishimoto A; Fujimoto S
Cancer Chemother Pharmacol; 2003 Jun; 51(6):512-8. PubMed ID: 12679883
[TBL] [Abstract][Full Text] [Related]
5. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
[TBL] [Abstract][Full Text] [Related]
6. Transport mechanism of pirarubicin in human mononuclear cells.
Nagasawa K; Tsumura A; Nomiyama M; Ohnishi N; Yokoyama T
Biol Pharm Bull; 1996 Sep; 19(9):1203-9. PubMed ID: 8889041
[TBL] [Abstract][Full Text] [Related]
7. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of daunorubicin and doxorubicin in HL60 and its resistant cells and comparison with those of pirarubicin.
Nagasawa K; Natazuka T; Nomiyama M; Ohnishi N; Yokoyama T
Biol Pharm Bull; 1996 Jan; 19(1):100-5. PubMed ID: 8820920
[TBL] [Abstract][Full Text] [Related]
8. Uptake of the anthracycline pirarubicin into mouse M5076 ovarian sarcoma cells via a sodium-dependent nucleoside transport system.
Nagai K; Nagasawa K; Fujimoto S
Cancer Chemother Pharmacol; 2005 Mar; 55(3):222-30. PubMed ID: 15526202
[TBL] [Abstract][Full Text] [Related]
9. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
[TBL] [Abstract][Full Text] [Related]
10. Characterization of equilibrative and concentrative Na+-dependent (cif) nucleoside transport in acute promyelocytic leukemia NB4 cells.
Roovers KI; Meckling-Gill KA
J Cell Physiol; 1996 Mar; 166(3):593-600. PubMed ID: 8600163
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside transporters are critical to the uptake and antioxidant activity of 7,8-dihydroneopterin in monocytic cells.
Janmale TV; Lindsay A; Gieseg SP
Free Radic Res; 2020 May; 54(5):341-350. PubMed ID: 32375530
[TBL] [Abstract][Full Text] [Related]
13. Contribution of specific transport systems to anthracycline transport in tumor and normal cells.
Nagasawa K; Nagai K; Ohnishi N; Yokoyama T; Fujimoto S
Curr Drug Metab; 2001 Dec; 2(4):355-66. PubMed ID: 11766987
[TBL] [Abstract][Full Text] [Related]
14. Characterization of nucleoside transport systems in cultured rat epididymal epithelium.
Leung GP; Ward JL; Wong PY; Tse CM
Am J Physiol Cell Physiol; 2001 May; 280(5):C1076-82. PubMed ID: 11287319
[TBL] [Abstract][Full Text] [Related]
15. Comparison of uptake mechanisms for anthracyclines in human leukemic cells.
Karim H; Bogason A; Bhuiyan H; Fotoohi AK; Lafolie P; Vitols S
Curr Drug Deliv; 2013 Aug; 10(4):404-12. PubMed ID: 23062181
[TBL] [Abstract][Full Text] [Related]
16. Contribution of an unidentified sodium-dependent nucleoside transport system to the uptake and cytotoxicity of anthracycline in mouse M5076 ovarian sarcoma cells.
Nagai K; Nagasawa K; Koma M; Kihara Y; Fujimoto S
Biochem Pharmacol; 2006 Feb; 71(5):565-73. PubMed ID: 16376308
[TBL] [Abstract][Full Text] [Related]
17. Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: effect of sodium fluoride on pirarubicin uptake.
Nagasawa K; Tsumura A; Kitazawa F; Nomiyama M; Ohnishi N; Yokoyama T
Biol Pharm Bull; 1995 Feb; 18(2):368-71. PubMed ID: 7742815
[TBL] [Abstract][Full Text] [Related]
18. Decrease in equilibrative uridine transport during monocytic differentiation of HL-60 leukaemia: involvement of protein kinase C.
Lee CW
Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):407-12. PubMed ID: 8002945
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
[TBL] [Abstract][Full Text] [Related]
20. Uptake and release of [3H]formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells.
Borgland SL; Parkinson FE
J Pharmacol Exp Ther; 1997 Apr; 281(1):347-53. PubMed ID: 9103516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
